Prospects for the development of a vaccine against Helicobacter pylori

Drugs

Volumn 52, Issue 6, 1996, Pages 799-804

  Telford, John L ^a   Ghiara, Paolo ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIAL VACCINE;

ANTIBIOTIC RESISTANCE; DRUG COST; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; PEPTIC ULCER; REVIEW; RISK; STOMACH ADENOCARCINOMA; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0029800676     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199652060-00002     Document Type: Review

References (36)

1. Blaser MJ. The bacteria behind ulcers. Sci Am 1996; 274: 104-7
2. Morris AJ, Ali MR, Nicholson GI, et al. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann Intern Med 1991; 114: 662-3
3. Sobala GM, Crabtree JE, Dixon MF, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991; 32: 1415-8
4. Marshall BJ. The Campylobacter pylori story. Scand J Gastroenterol Suppl. 1988; 146: 58-66
5. Tytgat GNJ. Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68
6. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31
7. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N End J Med 1994; 330: 1267-71
8. Mobley HL, Cortesia MJ, Rosenthal LE, et al. Characterization of urease from Campylobacter pylori. J Clin Microbiol 1988; 26: 831-6
9. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173: 1920-31
10. Josenhans C, Labigne A, Suerbaum S. Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J Bacteriol 1995; 177: 3010-20
11. Evans DG, Karjalainen TK, Evans Jr DJ, et al. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol 1993; 175: 674-83
12. O'Toole PW, Janzon L, Doig P, et al. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein. J Bacteriol 1995; 177: 6049-57
13. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-9
14. Telford JL, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8
15. Xiang ZY, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8
16. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5
17. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993; 12: 739-45
18. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5
19. Telford JL, Covacci A, Ghiara P, et al. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential for new therapies and vaccines. Trends Biotechnol 1994; 12: 420-6
20. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori - association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7
21. Ghiara P, Marchetti M, Blaser MJ, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun 1995; 63: 4154-60
22. Marchetti M, Arico B, Burroni D, et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8
23. Crabtree JE, Xiang Z, Lindley IJD, et al. Induction of interleukin-8 secretion from gastric epithelial cells by a CagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1995; 48: 967-9
24. Chen M, Lee A, Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model [letter]. Lancet 1992; 339: 1120-1
25. Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994; 12: 387-400
26. Corthesy-Theulaz I, Haas R, Davin C, et al. Helicobacter pylori urease protection against Helicobacter felis infection in mice. Acta Gastroenterol Belgica 1993; 56: 64
27. Ferrero RL, Thiberge JM, Huerre M, et al. Recombinant antigens prepared from the urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infect Immun 1994; 62: 4981-9
28. Michetti P, Corthesy-Theulaz I, Davin C, et al. Immunization of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterology 1994; 107: 1002-11
29. Ghiara P, Marchetti M, Di Tommaso A, et al. Infection by Helicobacter pylori in a mouse model that mimics human disease: protection by oral immunization [abstract]. Gut 1995; 37 Suppl. 1: A51
30. Ferrero RL, Thiberge JM, Kansau I, et al. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mite. Proc Natl Acad Sci USA. 1995; 92: 6499-503
31. Corthésy-Theulaz I, Vaney AC, Haas R, et al. H. pylori urease B subunit as a therapeutical vaccine against H. fells infection [abstract]. Gastroenterology 1994; 106 (4 Pt 2). A668
32. Doidge C, Gust I, Lee A, et al. Therapeutic immunisation against Helicobacter infection. Lancet 1994; 343: 914-5
33. Lee CK, Weltzin R, Thomas WD, et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995; 172: 161-72
34. Lee A, Chen MH. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infect Immun 1994; 62: 3594-7
35. Nedrud J, Blanchard T, Czinn S, et al. Recombinant cholera toxin B subunit is not an adjuvant for oral immunization against Helicobacter felis in mice [abstract]. J Cell Biochem 1995; Suppl. 19A: 261
36. Douce G, Trucotte C, Cropley I, et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 1995; 92: 1644-8